Berlin, Germany

Petra Knaus

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Biopharm Gesellschaft Zur Biotechnolgischen Entwicklung Von Pharmaka Mbh, Charité – Universitätsmedizin Berlin, Freie Universitat Berlin. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Petra Knaus. Retrieved from https://idiyas.com/inventor/petra-knaus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Petra Knaus: Innovator in Growth Factor Mutants

Introduction

Petra Knaus is a distinguished inventor based in Berlin, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of growth factor mutants with enhanced biological activity. Her innovative work has the potential to impact various medical applications.

Latest Patents

Petra Knaus holds 1 patent for her invention titled "Growth factor mutants with improved biological activity." This invention relates to novel biosynthetic growth factor mutants that exhibit improved biological activity, showcasing her expertise in the field.

Career Highlights

Throughout her career, Petra has worked with notable organizations, including Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka mbH and Charité - Universitätsmedizin Berlin. Her experience in these institutions has allowed her to advance her research and contribute to significant scientific advancements.

Collaborations

Petra has collaborated with esteemed colleagues, including Stefan Mundlos and Jens Pohl. These partnerships have further enriched her research and innovation in the biotechnology sector.

Conclusion

Petra Knaus is a remarkable inventor whose work in growth factor mutants exemplifies the intersection of science and innovation. Her contributions continue to pave the way for advancements in biotechnology and medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…